South Korea
· Delayed Price · Currency is KRW Hyundai Pharmaceutical Company Description
Hyundai Pharmaceutical Co., Ltd. manufactures and distributes pharmaceutical products, health food drinks, and medical devices in South Korea and internationally.
The company offers a range of ETC and OTC products in various therapeutic areas, including antianginal, antibiotic, antiemetics+antinauseants, antihistamines and antiallergics, antihyperlipidemic, antihypertensive, antiplatelet agent, antitussives, cell stimulants and proliferants, central nervous system, depilatory, dermatological agent, dermatology, dietary supplements, digestive system, endocrine system, expectorants, eye tonic and vitamins, gynaecolog antifungals, gynaecologic antiseptics, hemostatics, labour inhibitors, leukotriene modulator, narcotic analgesics, NSAIDs, oestrogens, ophthalmic products, OTH.sex horm and similar, SERMS, systemic hormonal contraceptives, urogenital system depilatory, uterotonic products, various alimentary tract and metabolism products, vitamins, acne, allergy, alopecia treatment, analgesics and anti-inflammatory, anemia, antimicrobial and antivirus, arthritis, contraceptives, dermatological agent, diagnostic reagent, gastrointestinal disorder and digestant, lip care, nutrition, ophthalmic product, respiratory, urogenital system, wound healing, and others.
Hyundai Pharmaceutical Co., Ltd. was founded in 1965 and is headquartered in Seoul, South Korea.
| Country | South Korea |
| Founded | 1965 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 393 |
| CEO | Young-Hak Kim |
Contact Details
Address: Hyundai Pharm Building Seoul, 06121 South Korea | |
| Website | hyundaipharm.co.kr |
Stock Details
| Ticker Symbol | 004310 |
| Exchange | Korea Stock Exchange |
| Fiscal Year | December - November |
| Reporting Currency | KRW |
| ISIN Number | KR7004310009 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Young-Hak Kim | Chief Executive Officer |